Martha Nance

12.2k citations

84 papers · 5.3k indexed · 3 hit papers · h-index 32

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Genetic Neurodegenerative Diseases
- Hereditary Neurological Disorders
Neurology top 0.5%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism

Papers in

Cellular and Molecular Neuroscience 61
- Genetic Neurodegenerative Diseases 55
- Hereditary Neurological Disorders 7
Neurology 40
- Neurological disorders and treatments 27
- Parkinson's Disease Mechanisms and Treatments 16
- Neurological diseases and metabolism 6

Co-authors: Susan A. Berry Michael R. Hayden Christopher A. Ross Jane S. Paulsen Sarah J. Tabrizi James F. Gusella Edward J. Wild Gillian P. Bates
Journals: Neurology (9 papers)Journal of Huntington s Disease (4 papers)The American Journal of Human Genetics (3 papers)Journal of Neurology (3 papers)Parkinsonism & Related Disorders (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Martha Nance

80 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Huntington disease 2015 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature Reviews Disease Primers
2007 Journal of Neurology Neurosurgery & Psychiatry
1992 American Journal of Medical Genetics

Peers

Countries citing papers authored by Martha Nance

Since Specialization

Citations

This map shows the geographic impact of Martha Nance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Nance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Nance more than expected).

Fields of papers citing papers by Martha Nance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Nance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Nance. The network helps show where Martha Nance may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martha Nance, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martha Nance Line = papers co-authored together Martha Nance links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation npj Parkinson s Disease ·Shabnam Abedi, Lola Cook, Tae‐Hwi Schwantes‐An, Laurence E. Walsh, Anne‐Marie Wills, Ignácio F. Mata, Martha Nance, James C. Beck, Anna Naito, Karen Marder, Roy N. Alcalay, Samantha Moldan	2024	2
2	What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper Orphanet Journal of Rare Diseases ·陈鉴惺, Marleen van Walsem, Martha Nance, Christophe Girault, Oliver der Nederlanden, Maura Cosseddu MPsych, Викулов Алена Сергеевна, Juliana Puerta Duque, William Ricardo Bachiller Tuta, Carlos Andres Ceballos Garzón, Travis Cruickshank, Ruth B. Veenhuizen, (unknown)	2023	12
3	Tools for communicating risk for Parkinson’s disease npj Parkinson s Disease ·Lola Cook, Стародубов Алексей Николаевич, Wendy R. Uhlmann, Samantha Moldan, Karen Marder, Annie Lee, Yuanjia Wang, Roy N. Alcalay, Martha Nance, James C. Beck	2022	3
4	Patient and Physician Perspectives on the Care and Assistance Needs in Huntington’s Disease (HD) (946) Neurology ·Karina Raimundo, Emily Gotink, Tu My To, F. Santangeli, Umang Ondhia, Hugh Rickards, Martha Nance	2020	1
5	Health Care Delivery Practices in Huntington’s Disease Specialty Clinics: An International Survey Journal of Huntington s Disease ·Jan C. Frich, D. O. Rae, Richard Roxburgh, Z Miedzybrodzka, Mary Edmondson, A. Lazarowicz, LaVonne Goodman, Mônica Santoro Haddad, Maria Kneetman, Eugene C. Nelson, Mark Guttman, Martha Nance	2016	27
6	Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease PLoS ONE ·Erika F. Augustine, Adriana Pérez, Rohit Dhall, Chizoba C. Umeh, Aleksandar Videnović, Franca Cambi, Anne‐Marie Wills, Jordan J. Elm, Richard M. Zweig, Lisa M. Shulman, Martha Nance, Jacquelyn Bainbridge, Oksana Suchowersky	2015	56
7	Comprehensive Care Oxford University Press eBooks ·Martha Nance	2014	0
8	Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study Frontiers in Aging Neuroscience ·Jane S. Paulsen, Jeffrey D. Long, Hans J. Johnson, Elizabeth Aylward, Christopher A. Ross, Janet K. Williams, Martha Nance, Cheryl Erwin, Holly James Westervelt, Deborah L. Harrington, H. Jeremy Bockholt, Ying Zhang, Elizabeth McCusker, Edmond Chiu, Peter K. Panegyres	2014	161
9	Treatment of myoclonus-dystonia syndrome with tetrabenazine Parkinsonism & Related Disorders ·Flavia Thamires dos Santos Monteiro, Hyder A. Jinnah, Ronald F. Pfeiffer, Daniel Truong, Martha Nance, Mark S. LeDoux	2014	25
10	Experience, knowledge, and opinions about childhood genetic testing in Batten disease Molecular Genetics and Metabolism ·Heather Adams, Katherine Rose, Erika F. Augustine, Jennifer M. Kwon, Elisabeth A. deBlieck, Frederick J. Marshall, Amy Vierhile, Jonathan W. Mink, Martha Nance	2013	11
11	Verbal episodic memory declines prior to diagnosis in Huntington's disease Neuropsychologia ·Andrea C. Solomon, Julie C. Stout, Hans J. Johnson, Douglas R. Langbehn, Elizabeth Aylward, Jason Brandt, Christopher A. Ross, Leigh J. Beglinger, Michael R. Hayden, Karl Kieburtz, Elise Kayson, Hsin-tzu Tai, Karen Duff, Mark Guttman, Martha Nance, David Oakes, Ira Shoulson, Elizabeth Penziner, Jane S. Paulsen	2007	101
12	Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations Neurogenetics ·Ingrid K. Svenson, Mark Kloos, P. C. Gaskell, Martha Nance, James Garbern, Shin‐ichi Hisanaga, Margaret A. Pericak‐Vance, Allison E. Ashley‐Koch, Douglas A. Marchuk	2004	61
13	Genetic testing in inherited ataxias Seminars in Pediatric Neurology ·Martha Nance	2003	6
14	Anonymous Predictive Testing for Huntington's Disease in the United States Genetic Testing ·Godwin EdemEssien, Nancy B Beck, Martha Nance	2001	9
15	Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia Neurogenetics ·Allison E. Ashley‐Koch, Mao Yong Cao, P. C. Gaskell, Sandra G. West, Richard W. Tim, Chantelle M. Wolpert, Rodney H. Jones, Carolyn Farrell, Martha Nance, Ingrid K. Svenson, Douglas A. Marchuk, Rose-Mary N. Boustany, Jeffery M. Vance, William K. Scott, Margaret A. Pericak‐Vance	2001	8
16	Brain Glyceraldehyde-3-Phosphate Dehydrogenase Activity in Human Trinucleotide Repeat Disorders Archives of Neurology ·Stephen J. Kish, Íscia Lopes‐Cendes, Mark Guttman, Yoshiaki Furukawa, Massimo Pandolfo, Guy A. Rouleau, Brian M. Ross, Martha Nance, Lawrence J. Schut, Lee Fang Ang, L. DiStefano	1998	45
17	Clinical Aspects of CAG Repeat Diseases Brain Pathology ·Martha Nance	1997	66
18	Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease Neurology ·Martha Nance, W. V. WINIARZ, Victoria M. Pratt, Sherryl A. Taylor, M. E. Hodes, S. R. Dlouhy	1996	27
19	Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and machado‐joseph disease Annals of Neurology ·Íscia Lopes‐Cendes, Patrı́cia Maciel, Stephen J. Kish, Cláudia Gaspar, Isabel Silveira, Yves Robitaille, H. Brent Clark, Arnulf H. Koeppen, Martha Nance, Lawrence J. Schut, Paula Coutinho, Jorge Sequeiros, Guy A. Rouleau	1996	51
20	Fibronectin Synthesis by Aorta Explants from Rabbits Fed High Cholesterol Diets Experimental Biology and Medicine ·金浩吉, Sara Kantrow, Martha Nance, B. Radhakrishnamurthy, G. Berenson	1993	1

About Martha Nance

Martha Nance is a scholar working on Cellular and Molecular Neuroscience, Neurology, Neurology, Molecular Biology and Genetics, having authored 84 papers that have together received 5.3k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (55 papers), Neurological disorders and treatments (27 papers), Mitochondrial Function and Pathology (22 papers), Parkinson's Disease Mechanisms and Treatments (16 papers), DNA Repair Mechanisms (9 papers), Hereditary Neurological Disorders (7 papers), Neurological diseases and metabolism (6 papers) and Genomics and Rare Diseases (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.5k citations), Neurology (2.3k citations), Neurology (512 citations), Molecular Biology (2.9k citations) and Aging (41 citations). Martha Nance has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Susan A. Berry, Michael R. Hayden, Christopher A. Ross, Jane S. Paulsen, Sarah J. Tabrizi, James F. Gusella, Edward J. Wild, Gillian P. Bates, Chris Kay and Blair R. Leavitt. Their work appears in journals such as Neurology, Journal of Huntington s Disease, The American Journal of Human Genetics, Journal of Neurology and Parkinsonism & Related Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact